Modernizing Pharmaceutical Manufacturing

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2002, Volume 26, Issue 2

FDA's Center for Drug Evaluation and Research is driving efforts toward creating initiatives to streamline regulatory processes, speed up drug production, and reduce costs.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-02-02-2002
Gilead Treatment for PBC Granted EC Conditional Marketing Authorization
Ask the Expert: Complying with 21 CFR 211.110
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment